Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvonne Collins

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Journal of Biological Chemistry|August 23, 2012
Inactivation of pyruvate dehydrogenase kinase 2 by mitochondrial reactive oxygen speciesThomas R Hurd, Yvonne Collins, Irina Abakumova, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 25, 2009
The Immune adjuvant properties of front-line carboplatin-paclitaxel: a randomized phase 2 study of alternative schedules of intravenous oregovomab chemoimmunotherapy in advanced ovarian cancerPatricia Braly, Christopher F Nicodemus, Christina Chu, et al.
International Journal of Molecular Medicine|June 18, 2004
Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarrayYvonne Collins, Dong Feng Tan, Tanja Pejovic, et al.
Free Radical Biology & Medicine|December 10, 2013
A mitochondria-targeted mass spectrometry probe to detect glyoxals: implications for diabetesPamela Boon Li Pun, Angela Logan, Victor Darley-Usmar, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Journal of Biological Chemistry|August 23, 2012
Inactivation of pyruvate dehydrogenase kinase 2 by mitochondrial reactive oxygen speciesThomas R Hurd, Yvonne Collins, Irina Abakumova, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 25, 2009
The Immune adjuvant properties of front-line carboplatin-paclitaxel: a randomized phase 2 study of alternative schedules of intravenous oregovomab chemoimmunotherapy in advanced ovarian cancerPatricia Braly, Christopher F Nicodemus, Christina Chu, et al.
International Journal of Molecular Medicine|June 18, 2004
Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarrayYvonne Collins, Dong Feng Tan, Tanja Pejovic, et al.
Free Radical Biology & Medicine|December 10, 2013
A mitochondria-targeted mass spectrometry probe to detect glyoxals: implications for diabetesPamela Boon Li Pun, Angela Logan, Victor Darley-Usmar, et al.
Pageof 2